Financial statements Cytopath
Cash flow statement of Cytopath
Company age:
Age:
10 y. 6 m. 19 d.
Share capital:
Share capital:
600 000 PLN
Cash inflows of CYTOPATH
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Net cash from operating expenses | -131 829,81 | -242 073,23 | -275 048,24 | 99 372,13 | 80 933,53 | -872 582,70 |
| Net cash flow from investing activities | -265 080,60 | 0,00 | 9 000,00 | 0,00 | 0,00 | -106 597,19 |
| Net cash flow from financial activities | 405 472,88 | 270 326,21 | 351 435,16 | -107 883,79 | -104 017,20 | 1 155 320,31 |
| Total net cash flow | 8 562,47 | 28 252,98 | 85 386,92 | -8 511,66 | -23 083,67 | 176 140,42 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.